London, England -- (SBWIRE) -- 05/30/2012 -- The flu vaccines market has been at the forefront of this trend, partially fuelled by the fear of an impending pandemic. As a result global influenza vaccine market has experienced phenomenal growth in recent years at a compound annual growth rate of more than 65% between 2008 and 2010. This growth was mainly driven by the global spread of H1N1 influenza. But in the year 2011 H1N1 pandemic flu vaccine market declined due to waning threat of swine flu disease. However seasonal influenza vaccine market is predicted to grow year on year and cross US$ 4 Billion by 2015.

For Sample Pages, please click or add the below link to your browser:
http://www.globalmarketsdirect.com/SamplePdfRequest.aspx?ID=Influenza-Vaccine-Market-Opportunities-and-Challenges-Worldwide-Forecast&Title=Pharmaceuticals_and_Healthcare&ReportType=Industry_Report&CompanyID=sbwirereportstore

From our research findings Unites States is the largest market for influenza vaccine market in 2010. In seasonal influenza vaccine brands like Fluarix & Flulaval had highest sales for 2010. Unlike some other pharmaceutical products, influenza vaccines are equally important in both developed and developing nations. In the developing countries, dealing with infectious diseases remains the highest priority in healthcare. It is predicted that in the next 5-6 years seasonal influenza vaccine sales would increase significantly.

Renub Research report entitled “Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast” critically examines the influenza vaccines market through a comprehensive review of information. This report provides market prospects, Key products detailed sales forecasts, discussions of pipeline developments and analyses of commercial drivers and challenges, including revenue of key players from seasonal and H1N1 influenza vaccine as well as Strengths and Weakness analysis of key players in influenza vaccine segment. This report examines the following markets for influenza vaccines:

Global Influenza vaccine market (2005 - 2015) Global Seasonal influenza vaccine market has been covered from (2003 – 2015) Global Swine Flu (H1N1) influenza vaccine market has been covered from (2009 – 2012) Top 7 Countries (United States, Germany, France, Italy, Spain, United Kingdom, Japan) seasonal vaccine market data from (2005 – 2015) Top Brands Seasonal influenza vaccine market performance (Fluarix, Afluria, Flumist, Influvac) market performance and forecast Top companies Swine Flu vaccine market performance (AstraZeneca, GlaxoSmithKline, Novartis, Sanofi-Pasteur)

For further details, please click or add the below link to your browser:
http://www.globalmarketsdirect.com/Report.aspx?ID=Influenza-Vaccine-Market-Opportunities-and-Challenges-Worldwide-Forecast&ReportType=Industry_Report&Title=Pharmaceuticals_and_Healthcare&CompanyID=sbwirereportstore

Visit our report store: http://www.globalmarketsdirect.com

For more details contact:
pressreleases@globalmarketsdirect.com

North America:
+1 646 395 5477
Europe:
+44 207 753 4299
+44 1204 543 533
Asia Pacific:
+91 40 6616 6782